The endocrine response to severe burn trauma

References

• Peck M. Epidemiology of burns throughout the world. Part I: distribution and risk factors. Burns 37(7), 1087–1100 (2010).
   Google Scholar
• Jeschke M, Mlcak R, Finnerty C et al. Burn size determines the inflammatory and hypermetabolic response. Crit. Care 11(4), R90 (2007).
   PubMed Web of Science ®Google Scholar
• Jeschke M, Gauglitz G, Kulp G et al. Long-term persistence of the pathophysiological responses to severe burn injury. PLoS ONE 6(7), e21245 (2007).
   Google Scholar
• Przkora R, Jeschke M, Barrow R et al. Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment. Ann. Surg. 242(3), 384–391 (2005).
   PubMedGoogle Scholar
• Hart D, Wolfe S, Mlcak R et al. Persistence of muscle catabolism after severe burn. Surgery 128(2), 312–219 (2000).
   Google Scholar
• Kraft R, Herndon D, Al-Mousawi A, Willians F, Finnerty C, Jeschke M. Burn size and survival probability in paediatric patients in modern burn care: a prospective observational cohort study. Lancet 379(9820), 1013–1021 (2012).
   PubMedGoogle Scholar
• Dolecek R. Endocrine changes after burn trauma a review. Keio J. Med. 38(3), 262–276 (1989).
   Google Scholar
• Senel E, Kizilgun M, Akbiyik F, Atayurt H, Tiryaki H, Aycan Z. The evaluation of the adrenal and thyroid axes and glucose metabolism after burn injury in children. J. Pediatr. Endocrinol. Metab. 23(5), 481–489 (2010).
   Google Scholar
• Burton D, Nicholson G, Hall G. Endocrine and metabolic response to surgery. Contin. Educ. Anaesth. Crit. Care Pain 4(5), 144–147 (2004).
   Google Scholar
• Dolecek R, Tymonova J, Adamkova M, Kadlcik M, Pohlidal A, Zavodna R. Endocrine changes after burns: the bone involvement. Acta. Chir. Plast. 45(3), 95–103 (2003).
   Google Scholar
• Calvano S, Chiao J, Reaves L, Antonacci A, Shires G. Changes in free and total levels of plasma cortisol and thyroxine following thermal injury in man. J. Burn Care Res. 5(2), 143–149 (1984).
   Google Scholar
• Tredget E, Yu Y. The metabolic effects of thermal injury. World J. Surg. 16(1), 68–79 (1992).
   Google Scholar
• Rojas Y, Finnerty C, Radhakrishnan R, Herndon D. Burns: an update on current pharmacotherapy. Expert Opin. Pharmacother. 13(17), 2485–2494 (2012).
   PubMed Web of Science ®Google Scholar
• Pereira C, Jeschke M, Herndon D. Beta-blockade in burns. Novartis Found Symp. 280, 238–251 (2007).
   Google Scholar
• The Global Burden of Disease: 2004 Update. WHO, Geneva, Switzerland (2008).
   Google Scholar
• Mlcak R, Jeschke M, Barrow R, Herndon D. The influence of age and gender on resting energy expenditure in severely burned children. Ann. Surg. 224(1), 121–130 (2006).
   Google Scholar
• Norbury W, Herndon D. Modulation of the hypermetabolic response after burn injury. In: Total Burn Care (3rd Edition). Saunders Elsevier, NY, USA 420–433 (2007).
   Google Scholar
• Przkora R, Barrow R, Jeschke M et al. Body composition changes with time in pediatric burn patients. J. Trauma 60(5), 968–971 (2006).
   PubMedGoogle Scholar
• Jeffries M, Vance M. Growth hormone and cortisol secretion in patients with burn injury. J. Burn Care Rehabil. 13(4), 391–395 (1992).
   Google Scholar
• Klein G, Bi L, Sherrard D et al. Evidence supporting a role of glucocorticoids in short-term bone loss in burned children. Osteoporos. Int. 15(6), 468–474 (2004).
   Google Scholar
• Goodall M, Stone C, Haynes B. Urinary output of adrenaline and noradrenaline in severe thermal burns. Ann. Surg. 145(4), 479–487 (1957).
   Google Scholar
• Coombes E, Batstone G. Urine cortisol levels after burn injury. Burns Incl. Therm. Inj. 8(5), 333–337 (1982).
   Google Scholar
• Wilmore D, Long J, Mason A et al. Catecholamines; mediator of the hypermetabolic response to thermal injury. Ann. Surg. 180(4) 653–669 (1974).
   PubMedGoogle Scholar
• Pereira C, Murphy K, Herndon D. Altering metabolism. J. Burn Care Rehabil. 26(3), 194–199 (2005).
   PubMedGoogle Scholar
• Rennie M. Muscle protein turnover and the wasting due to injury and disease. Br. Med. Bull. 41(3), 257–264 (1985).
   Google Scholar
• Arnold J, Campbell I, Samuels T et al. Increased whole body protein breakdown predominates over increased whole body protein synthesis in multiple organ failure. Clin. Sci. 84(6), 655–661 (1993).
   Google Scholar
• Biolo G, Tipton K, Klein S, Wolfe R. An abundant supply of amino acids enhances the metabolic effect of exercise on muscle protein. Am. J. Physiol. 273(1 Pt 1), E122–E129 (1997).
   PubMed Web of Science ®Google Scholar
• Biolo G, Toigo G, Ciocchi B et al. Metabolic response to injury and sepsis: changes in protein metabolism. Nutrition 13(9) 52S–57S (1997).
   Google Scholar
• Herndon D, Tompkins R. Support of the metabolic response to burn injury. Lancet 363(9424), 1895–1902 (2004).
   PubMed Web of Science ®Google Scholar
• Williams F, Jeschke M, Chinkes D et al. Modulation of the hypermetabolic response to trauma: temperature, nutrition, and drugs. J. Am. Coll. Surg. 208(4), 489–502 (2009).
   PubMed Web of Science ®Google Scholar
• Jeschke M, Chinkes D, Finnerty C et al. Pathophysiologic response to severe burn injury. Ann. Surg. 248(3), 387–401 (2008).
   PubMed Web of Science ®Google Scholar
• Pereira C, Murphy K, Jeschke M, Herndon D. Post burn muscle wasting and the effects of treatments. Int. J. Biochem. Cell. Biol. 37(10), 1948–1961 (2005).
   PubMed Web of Science ®Google Scholar
• Vanhorebeek I, Langouche L, Van den Berghe G. Endocrine aspects of acute and prolonged critical illness. Nat. Clin. Pract. Endocrinol. Metab. 2(1), 20–31 (2006).
   Google Scholar
• Guvener M, Pasaoglu I, Demircin M, Oc M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr. J. 49(5), 531–537 (2002).
   PubMed Web of Science ®Google Scholar
• Gore D, Chinkes D, Heggers J et al. Association of hyperglycemia with increased mortality after severe burn injury. J. Trauma 51(3), 540–544 (2001).
   PubMedGoogle Scholar
• Thorell A, Efendic S, Gutniak M, Haggmark T, Ljungqvist O. Development of postoperative insulin resistance is associated with the magnitude of operation. Eur. J. Surg. 159(11–12), 593–599 (1993).
   Google Scholar
• Garcia-Avello A, Lorente J, Cesar-Perez J et al. Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma. Thromb. Res. 89(2), 59–64 (1998).
   PubMed Web of Science ®Google Scholar
• Christiansen C, Toft P, Jorgensen H, Andersen S, Tonnesen E. Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med. 30(8), 1685–1688 (2004).
   Google Scholar
• World Health Organization. A graphical overview of the global burden of injuries. In: The Injury Chart Book. WHO, Geneva, Switzerland 29 (2002).
   Google Scholar
• Pereira C, Barrow R, Sterns A et al. Age-dependent differences in survival after severe burns: a unicentric review of 1,674 patients and 179 autopsies over 15 years. J. Am. Coll. Surg. 202(3), 536–548 (2006).
   Google Scholar
• Matsui M, Kudo T, Kudo M, Ishihara H, Matsuki A. The endocrine response after burns. Agressologie 32(4), 233–235 (1991).
   Google Scholar
• Smith A, Barclay C, Quaba A et al. The bigger the burn, the greater the stress. Burns 23(4), 291–294 (1997).
   Google Scholar
• Cioffi W, Vaughan G, Heironimus J, Jordan B, Mason A, Pruit B. Dissociation of blood-volume and flow in regulation of salt and water - balance in burn patients. Ann. Surg. 214(3), 213–220 (1991).
   Google Scholar
• Carvajal H. Fluid resuscitation of paediatric burn victims - a critical appraisal. Pediatr. Nephr. 8(3), 357–366 (1994).
   Google Scholar
• Stark H, Weinberger A, Benbassat M. Persistent hyponatremia and inappropriate anti-diurectic hormone-secretion in children with extensive burns. J. Pediatr. Surg. 14(2), 149–153 (1979).
   Google Scholar
• Morgan R, Martyn J, Philibin D, Coggins C, Burke J. Water metabolism and antidiuretic hormone (ADH) response following thermal injury. J. Trauma 20(6), 468–472 (1980).
   Google Scholar
• Shirani K, Vaughan G, Robertson G et al. Inappropriate vasopressin secretion (SIADH) in burned patients. J. Trauma 23(3), 217–224 (1983).
   Google Scholar
• Hauben D, Le Roith D, Glick S, Mahler D. Nonoliguric vasopressin over-secretion in severely burned patients. Isr. J. Med. Sci. 16(2), 101–105 (1980).
   Google Scholar
• Murton S, Tan S, Prickett T, Frampton C, Donald RA. Hormone responses to stress in patients with major burns. Brit. J. Plast. Surg. 51(5), 388–392 (1998).
   Google Scholar
• Dolecek R, Adamkova M, Sotornikova T, Zavada M, Kracmar P. Endocrine response after burn. Scand. J. Plast. Reconstr. Surg. 13(1), 9–16 (1979).
   PubMed Web of Science ®Google Scholar
• Jadhav S, Sharma N, Meeks C et al. Effects of combined radiation and burn injury on the renin-angiotensin system. Wound Repair Regen. 21(1), 131–140 (2013).
   PubMed Web of Science ®Google Scholar
• Akrami C, Falkner B, Gould A, DeClement F, Bendlin A. Plasma-renin and occurrence of hypertension in children with burn injuries. J. Trauma 20(2), 130–134 (1980).
   Google Scholar
• Liu D, Yang Z, Li A. Plasma renin activity (PRA), angiotensin II (AII), atrial natriuretic peptide (ANP) and AII/ANP ratio in severely burned patients. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi. 10(2), 117–120 (1994).
   Google Scholar
• Popp M, Silberstein E, Srivastava L, Loggie J, Knowles H, MacMillan B. A patholophysiologic study of the hypertension associated with burn injury in children. Ann. Surg. 193(6), 817–824 (1981).
   Google Scholar
• Onuoha G, Alpar E, Gowar J. Plasma levels of atrial natriuretic peptide in severe burn injury. Burns 26(5), 449–453 (2000).
   Google Scholar
• Briziomolteni L, Molteni A, Warpeha R, Angelats J, Lewis N, Fors E. Prolactin, corticotropin, and gonadotropin, and gonadotropin concentrations following thermal-injury in adults. J. Trauma 24(1), 1–7 (1984).
   Google Scholar
• Woolf P. Hormonal responses to trauma. Crit. Care Med. 20(2), 216–226 (1992).
   Google Scholar
• Vaughan G, Becker R, Allen J, Goodwin C, Pruitt B, Mason A. Cortisol and corticotropin in burned patients. J. Trauma 22(4), 263–273 (1982).
   Google Scholar
• Cohen J, Deans R, Dalley A et al. Measurement of tissue cortisol levels in patients with severe burns: a preliminary investigation. Critical Care 13(6), R189 (2009).
   Google Scholar
• Pamieri T, Levine S, Schonfeld-Warden N et al. Hypothalamic-pituitary-adrenal axis response to sustained stress after major burn injury to children. J. Burn Care Res. 27(5), 742–748 (2006).
   Google Scholar
• Fuchs P, Groger A, Bozkurt A, Johnen D, Wolter T, Pallua N. Cortisol in severely burned patients: Investigations on disturbance of the hypothalamic-pituitary-adrenal axis. Shock 28(6), 662–667 (2007).
   Google Scholar
• Murphy J, Purdue G, Hunt J. Acute adrenal insufficiency in the patient with burns. J. Burn Care Rehabil. 14(2 Pt 1), 155–157 (1993).
   Google Scholar
• Klein G. The interaction between burn injury and vitamin D metabolism and consequences for the patient. Curr. clin. pharmacol. 3(3), 204–210 (2008).
   Google Scholar
• Jeschke M, Williams F, Finnerty C et al. The effect of ketoconazole on post-burn inflammation, hypermetabolism and clinical outcomes. PloS ONE 7(5), e35465 (2012)
   PubMedGoogle Scholar
• Lephart E, Baxter C, Parker C. Effect of burn trauma on adrenal and testicular-steroid hormone production. J. Clin. Endocrinol. Metab. 64(4), 842–848 (1987).
   Google Scholar
• Parker C, Baxter C. Divergence in adrenal-steroid secretory pattern after thermal-injury in adult patients. J. Trauma 25(6), 508–510 (1985).
   Google Scholar
• Elijah I, Branski L, Finnerty C, Herndon D. The GH/IGF-1 system in critical illness. Best Pract. Res. Clin. Endocrinol. Metab. 25(5), 759–767 (2011).
   Google Scholar
• Knox J, Demling R, Wilmore D, Sarraf P, Santos A. Increased survival after major thermal-injury - the effect of growth-hormone therapy in adults. J. Trauma 39(3), 526–532 (1995).
   Google Scholar
• Herndon D, Hawkins H, Nguyen T et al. Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann. Surg. 221(6), 649–656 (1995).
   PubMedGoogle Scholar
• Takagi K, Suzuki F, Barrow R, Wolf S, Herndon D. Recombinant human growth hormone modulates Th1 and Th2 cytokine response in burned mice. Ann. Surg. 228(1), 106–111 (1998).
   Google Scholar
• Takagi K, Suzuki F, Barrow R et al. Growth hormone improves immune function and survival in burned mice infected with herpes simplex virus type 1. J. Surg. Res. 69(1), 166–170 (1997).
   Google Scholar
• Gore D, Honeycutt D, Jahoor F, Wolfe R, Herndon D. Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch. Surg. 126(1), 38–43 (1991).
   Google Scholar
• Breederveld R, Tuinebreijer W. Recombinant human growth hormone for treating burns and donor sites. Cochrane Database of Syst. Rev. 12(12), 50 (2012).
   Google Scholar
• Luo X, Cen Y, Yu R, Zhao J. Effectiveness of recombinant human growth hormone treatment for severe burn injury. J. West China Univer. Med. Sci. 31(3), 399–401 (2000).
   Google Scholar
• Gauglitz G, Williams F, Herndon D, Jeschke M. Burns: where are we standing with propranaolol, oxandrolone, rhGH, and the new incretin analogues? Curr. Opin. Clin. Nutr. Metab. Care 14(2), 176–181 (2011).
   Google Scholar
• Takala J, Ruokonen E, Webster N et al. Increased mortality associated with growth hormone treatment in critically ill adults. N. Engl. J. Med. 341, 785–792 (1999).
   PubMed Web of Science ®Google Scholar
• Jeschke M, Finnety C, Kulp G, Przkora R, Mlack R, Herndon D. Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children. Pediatr. Crit. Care Med. 9(2), 209–216 (2008).
   PubMedGoogle Scholar
• Jeschke M, Herndon D, Barrow R. Insulin-like growth factor 1 in combination with insulin-like growth factor binding protein 3 affects the hepatic acute phase response and hepatic morphology in thermally injured rats. Ann. Surg. 231(3), 208–216 (2000).
   Google Scholar
• Debroy M, Wolf S, Zhang X et al. Anabolic effects of insulin-like growth factor in combination with insulin-like growth factor binding protein-3 in severely burned adults. J. Trauma 47(5), 904–911 (1999).
   Google Scholar
• Herndon D, Ramzy P, Debroy M et al. Muscle protein catabolism after severe burn, effects of IGF-1/IGFBP3 treatment. Ann. Surg. 229(5), 713–720 (1999).
   PubMed Web of Science ®Google Scholar
• Jeschke M, Barrow R, Suzuki F et al. IGF-I/IGFBP-3 equilibrates ratios of pro- to anti-inflammatory cytokines, which are predictors for organ function in severely burned pediatric patients. Mol. Med. 8(5), 238–246 (2002).
   Google Scholar
• Becker R, Vaughan G, Ziegler M et al. Hypermetabolic low triiodothyronine syndrome of burn injury. Crit. Care Med. 10(12), 870–875 (1982).
   Google Scholar
• Yang H, Yu X, Zhang Y. Free thyroxine in burn patient and its clinical significance. Chinese J. Plast. Surg. Burns 10(2), 121–123 (1994).
   Google Scholar
• Gangemi E, Garino F, Berchialla P et al. Low triiodothyronine serum levels as a predictor of poor prognosis in burn patients. Burns 34(6), 817–824 (2008).
   Google Scholar
• Schilling J, Zimmermann, TM Albrecht S, Zwipp H, Saeger H. Low T3 syndrome in patients with major trauma - Phenomenon or important pathogenic factor? Med. Klin. 94(3), 66–69 (1999).
   Google Scholar
• Plymate S, Vaughan G, Mason A, Pruitt B. Central hypogonadism in burned men. Horm. Res. 27(3), 152–158 (1987).
   Google Scholar
• Smeds S, Kagedal B, Leiden G, Lilijedahl S. Thyroid-function after thermal trauma. Scand. J. Plast. Reconstr. Surg. 15(2), 141–148 (1981).
   PubMed Web of Science ®Google Scholar
• Connolly C, Barrow R, Chinkes D, Martinez J, Herndon D. Recombinant human growth hormone increases thyroid hormone-binding sites in recovering severely burned children. Shock 19(5), 399–403 (2003).
   Google Scholar
• Vaughan G, Mason A, McManus W et al. Alterations of mental status and thyroid-hormones after thermal injury. J. Clin. Endocrinol. Metab. 60(6), 1221–1225 (1985).
   Google Scholar
• Kuhn J, Rieu M, Wasserman D et al. Thyroid-function in burned patients - influence of topical iodine therapy. Revue Med. Interne. 8(1), 21–26 (1987).
   Google Scholar
• Preissler P. Changes in thyroid-hormone levels in severely burned patients treated topically with povidone-iodine. Langenbecks Archiv. Fur. Chir. 360(1), 9–15 (1983).
   Google Scholar
• Kien C, Vanjonack W, Bode H. Low serum reverse T3 concentration in burned children: its relationship to nutritional state. Am. J. Clin. Nutr. 33(6), 1215–1219 (1980).
   Google Scholar
• Becker R, Vaughan G, Goodwin C et al. Plasma norepinephrine, epinephrine, and thyroid-hormone interactions in severely burned patients. Arch. Surg. 115(4), 439–443 (1980).
   Google Scholar
• Dolecek R, Dvoracek C, Jezek M, Kubis M, Sajnar J, Zavada M. Very low serum testosterone levels and severe impairment of spermatogenesis in burned male-patients - correlations with basal levels and levels of FSH, LH and PRL after LHRH + TRH. Endocrinol. Exp. 17(1), 33–45 (1983).
   Google Scholar
• Da M, Ma K, Duan T. Clinical studies on the effects of burn trauma on pituitary-testis axis. Chinese J. Plast. Surg. Burns 15(5), 373–375 (1999).
   Google Scholar
• Wang J, Zheng F, Shi X. The clinical significance of the change of blood testosterone in burned patients. Chinese J. Burns 16(2), 106–107 (2000).
   Google Scholar
• Diem E, Schmid R, Schneider W, Spona J. Influence of burn trauma on the hypothalamus-pituitary axis in normal female subjects. Scand. J. Plast. Reconstr. Surg. 13(1), 17–20 (1979).
   PubMed Web of Science ®Google Scholar
• Dugan A, Malarkey W, Schwemberger S, Jauch E, Ogle C, Horseman N. Serum levels of prolactin, growth hormone, and cortisol in burn patients: correlations with severity of burn, serum cytokine levels, and fatality. J. Burn Care Rehabil. 25(3), 306–313 (2004).
   Google Scholar
• Goyal N, Gore M, Shankar R. Galactorrhea and amenorrhea in burn patients. Burns 34(6), 825–828 (2008).
   Google Scholar
• Semple C, Robertson W, Mitchell R et al. Mechanisms leading to hypogonadism in men with burns injuries. Br. Med. J. 295(6595), 403–407 (1987).
   Google Scholar
• Jeschke M, Finnerty C, Suman O et al. The effect of Oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann. Surg. 246(3), 351–362 (2007).
   PubMedGoogle Scholar
• Ferrando A, Sheffield-Moore M, Wolf S, Herndon D, Wolfe R. Testosterone administration in severe burns ameliorates muscle catabolism. Crit. Care Med. 29(10), 1936–1942 (2001).
   PubMedGoogle Scholar
• Murphy K, Lee J, Herndon D. Current pharmocotherapy for the treatment of severe burns. Expert Opin. Pharmacother. 4(3), 369–384 (2003).
   PubMed Web of Science ®Google Scholar
• Tuvdendori D, Chinkes D, Zhang X et al. Long-term oxandrolone treatment increases muscle protein net deposition via improving amino acid utilization in pediatric patients 6 months after burn injury. Surgery 149(5), 645–653 (2011).
   Google Scholar
• Demling R, DeSanti L. Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns. J. Trauma 43(1), 47–51 (1997).
   PubMed Web of Science ®Google Scholar
• Hart D, Wolfe S, Ramzy P et al. Anabolic effects of oxandrolone after severe burn. Ann. Surg. 233(4), 556–64 (2001).
   PubMed Web of Science ®Google Scholar
• Miller J, Btaiche I. Oxandrolone Treatment in adults with severe thermal injury. Pharmacotherapy 29(2), 213–226 (2009).
   PubMedGoogle Scholar
• Klein G, Przkora R, Herndon D. Effects of burn injury on bone and mineral metabolism. In: Total Burn Care (3rd Edition). Saunders Elsevier, New York, NY, USA 420–433 (2007).
   Google Scholar
• Klein G. Burns: where has all the calcium (and vitamin D) gone? Adv. Nutr. 2(6), 457–462 (2011).
   Google Scholar
• Klein G, Nicolai M, Langman C, Cuneo B, Sailer D, Herndon D. Dysregulation of calcium homeostasis after severe burn injury in children: possible role of magnesium depletion. J. Pediatr. 131(2), 246–251 (1997).
   Google Scholar
• Klein G, Langman C, Herndon D. Persistent hypoparathyroidism following magnesium repletion in burn-injured children. Pediatr. Nephrol. 14(4), 301–304 (2000).
   Google Scholar
• Murphey E, Chattopadhyay N, Bai M et al. Up-regulation of the parathyroid calcium-sensing receptor after burn injury in sheep: a potential contributory factor to postburn hypocalcemia. Crit. Care Med. 28(12), 3885–3890 (2000).
   Google Scholar
• Nielsen P, Rasmussen A, Butters R et al. Inhibition of PTH secretion by interleukin-1 beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium sensing receptor mRNA. Biochem. Biophys. Res. Commun. 238(3), 880–885 (1997).
   Google Scholar
• Toribio R, Kohn, W, Capen, C, Rosol T. Parathyroid hormone (PTH) secretion, PTH mRNA and calcium-sensing receptor mRNA expression in equine parathyroid cells, and effects of interleukin (IL)-1, IL-6, and tumor necrosis factor-alpha on equine parathyroid cell function. J. Mol. Endocrinol. 31(3), 609–620 (2003).
   Google Scholar
• Canaff L, Zhou X, Hendy G. The proinflammatory cytokine, interleukin-6, up-regulates calcium-sensing receptor gene transcription via Stat1/3 and Sp1/3. J. Biol. Chem. 283(20), 13586–15600 (2008).
   PubMed Web of Science ®Google Scholar
• Klein G, Xie Y, Qin Y et al. Preliminary evidence of early bone resorption in a sheep model of acute burn injury: an observational study. J. Bone Miner. Metab. (2013).
   Google Scholar
• Klein G, Chen T, Holick M et al. Synthesis of vitamin D in skin after burns. Lancet 363(9405), 291–292 (2004).
   PubMed Web of Science ®Google Scholar
• Klein G, Herndon D, Rutan T et al. Bone disease in burn patients. J. Bone Miner. Res. 8(3), 337–345 (1993).
   Google Scholar
• Klein G, Herndon D, Langman C et al. Long-term reduction in bone mass after severe burn injury in children. J. Pediatr. 126(2), 252–256 (1995).
   Google Scholar
• Loghmani S, Maracy M, Kheirmand R. Serum phosphate level in burn patients. Burns 36(7), 1112–1115 (2010).
   Google Scholar
• Yang H, Yim H, Cho Y et al. Change of serum phosphate level and clinical outcome of hypophosphatemia in massive burn patient. J. Trauma Acute Care Surg. 73(5), 1298–1302 (2012).
   Google Scholar
• Berger M, Rothen C, Cavadini C, Chiolera R. Exudative mineral losses after serious burns: a clue to the alterations of magnesium and phosphate metabolism. Am. J. Clin. Nutr. 65(5), 1473–1481 (1997).
   Google Scholar
• Edelman L, McNaught T, Chan G, Morris S. Sustained bone mineral density changes after burn injury. J. Surg. Res. 114(2), 172–178 (2003).
   Google Scholar
• Klein G. Burn-induced bone loss: importance, mechanisms, and management. J. Burns Wounds 5(5), e5 (2006).
   Google Scholar
• Klein G, Herndon D, Goodman W et al. Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone 17(5), 455–460 (1995).
   PubMed Web of Science ®Google Scholar
• Klein G, Langman C, Herndon D. Vitamin D depletion following burn injury in children: a possible factor in post-burn osteopenia. J. Trauma 52(2), 346–350 (2002).
   Google Scholar
• Klein G, Herndon D. The role of bone densitometry in the diagnosis and management of the severely burned patient with bone loss. J. Clin. Densitom. 2(1), 11–15 (1999).
   Google Scholar
• Klein G, Wimalawansa S, Kulkarni G, Sherrard D, Sanford A, Herndon D. The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study. Osteoporos. Int. 16(6), 631–635 (2005).
   Google Scholar
• Przokra R, Herndon D, Sherrard D, Chinkes, D, Klein, G. Pamidronate preserves bone mass for at least 2 years following acute administration for paediatric burn injury. Bone 41(2), 297–302 (2007).
   Google Scholar
• Porro L, Herndon D, Rodriguez N et al. Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy. J. Am. Coll. Surg. 214(4), 489–502 (2012).
   PubMedGoogle Scholar
• Klein G, Herndon D, Chen T, Kulp G, Holick M. Standard multivitamin supplementation does not improve vitamin D insufficiency after burns. J. Bone Miner. Metab. 27(4), 502–506 (2009).
   Google Scholar
• Raab W. Key position of catecholamines in functional and degenerative cardiovascular pathology. Am. J. Cardiol. 5(5), 571–578 (1960).
   Google Scholar
• Norbury W, Herndon D, Branski L, Chinkes D, Jeschke M. Urinary cortisol and catecholamine excretion after burn injury in children. J. Clin. Endocrinol. Metab. 93(4), 1270–1275 (2008).
   Google Scholar
• Loven L, Nordstrom H, Lennquist S. Changes in calcium and phosphate and their regulating hormones in patients with severe burn injuries. Scand. J. Plast. Reconstr. Surg. 18(1), 49–53 (1984).
   PubMed Web of Science ®Google Scholar
• Arbabi S, Ahrns K, Wahl W et al. Beta-blocker use is associated with improved outcomes in adult burn patients. J. Trauma 56(2), 265–269 (2004).
   Google Scholar
• Herndon D, Rodriguez N, Diaz E et al. Long-term propranolol use in severely burned pediatric patients: a randomized placebo-controlled study. Ann. Surg. 256(3), 402–411 (2012).
   PubMedGoogle Scholar
• Minifee P, Barrow R, Abston S et al. Improved myocardial oxygen utilization following propranolol infusion in adolescents with postburn hypermetabolism. J. Pediatr. Surg. 24(8), 806–810 (1989).
   PubMedGoogle Scholar
• 138 Wolfe, R Herndon D, Peters E et al. Regulation of lioplysis in severely burned children. Ann. Surg. 206(2), 214–221 (1987).
   Google Scholar
• Barrow R, Wolfe R, Dasu M et al. The use of beta-adrenergic blockade in preventing trauma-induced hepatomegaly. Ann. Surg. 243(1), 115–120 (2006).
   PubMedGoogle Scholar
• Herndon D, Hart D, Wolfe S et al. Reversal of catabolism by beta-blockade after severe burns. N. Engl. J. Med. 345(17), 1223–1229 (2001).
   PubMed Web of Science ®Google Scholar
• 141 Brooks, N, Song J, Boehning, D et al. Propranolol improves impaired hepatic P12K/Akt signaling post burn injury. Mol. Med. 18(1), 707–711 (2012).
   Google Scholar
• Olah G, Finnerty C, Sbrana E et al. Increased poly (ADP-ribosyl) ation in skeletal muscle tissue of pediatric patients with severe burn injury: prevention by propranolol treatment. Shock 36(1), 18–23 (2011).
   PubMedGoogle Scholar
• Mohammadi A, Bakhshaeekia A, Alibeigi P et al. Efficacy of propranolol in wound healing for hospitalized burn patients. J. Burn Care Res. 30(6), 1013–1017. (2009).
   PubMed Web of Science ®Google Scholar
• Romana-Souza B, Nascimento A, Monte-Alto-Costa A. Low-dose propranolol improves cutaneous wound healing of burn-injured rats. Plast. Recontr. Surg. 122(6), 160–169 (2008).
   Google Scholar
• Oberbeck R, Schmitz D, Wilsenack K et al. Adrenergic modulation of survival and cellular immune functions during polymicrobial sepsis. Neuroimmunomodulation 11(4), 214–223 (2004).
   PubMedGoogle Scholar
• Wilson J, Higgings D, Hutting H et al. Early propranolol treatment induces lung heme-oxygenase-1, attenuates metabolic dysfunction, and improves survival following experimental sepsis. Crit. Care 17(5), R195 (2013)
   Google Scholar
• Mowlavi A, Andrews K, Milner S, Herndon D, Heggers J. The effects of hyperglycemia on skin graft survival in the burn patient. Ann. Plast. Surg. 45(6), 629–632 (2000).
   Google Scholar
• McMurry J. Wound healing with diabetes mellitus. better glucose control for better wound healing in diabetes. Surg. Clin. North Am. 64(4), 769–778 (1984).
   PubMed Web of Science ®Google Scholar
• McCowen K, Malhotra A, Bistrian B. Stress-induced hyperglycemia. Crit. Care Clin. 17(1), 107–124 (2001).
   PubMedGoogle Scholar
• Van den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in the medical ICU. N. Engl. J. Med. 354(5), 449–461 (2006).
   PubMed Web of Science ®Google Scholar
• Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N. Engl. J. Med. 345(19), 1359–1367 (2001).
   PubMed Web of Science ®Google Scholar
• Van den Berghe G, Wouters P, Bouillon R et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit. Care Med. 31(2), 359–366 (2003).
   PubMed Web of Science ®Google Scholar
• Jeschke M, Kulp G, Kraft R et al. Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial. Am. J. Resp. Crit. Care Med. 182(3), 351–9 (2010).
   PubMed Web of Science ®Google Scholar
• Sood R, Zieger M, Roggy D et al. The effectiveness of a computerized iv infusion protocol to treat hyperglycemia in burn patients. J. Burn Care Res. 33(5), 638–641 (2012).
   PubMedGoogle Scholar
• Tuvdendorj D, Zhang X, Chinkes D et al. Intensive insulin treatment increases donor site wound protein synthesis in burn patients. Surgery 149(4), 512–518 (2011).
   PubMedGoogle Scholar
• Thomas S, Morimoto K, Herndon D et al. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery 132(2), 341–347 (2002).
   PubMedGoogle Scholar
• Gore D, Wolf S, Herndon D et al. Metformin blunts stress-induced hyperglycemia after thermal injury. J. Trauma 54(3), 555–561 (2003).
   PubMedGoogle Scholar
• Cree M, Zwetsloot J, Herndon D et al. Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate. Ann. Surg. 245(2), 214–221 (2007).
   PubMedGoogle Scholar
• Shen C, Fagan S, Fischman A et al. Effects of glucagon-like peptide 1 on glycemia control and its metabolic consequence after severe thermal injury-studies in an animal model. Surgery 149(5), 635–644 (2011).
   Google Scholar
• Deane A, Chapman M, Fraser R, Burgstad C, Besanko L, Horowtiz M. The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study. Crit. Care 13(3), R67 (2009).
   PubMedGoogle Scholar
• Mecott G, Herndon D, Kulp G et al. The use of exenatide in severely burned pediatric patients. Crit. Care 14(4), R153 (2010).
   PubMedGoogle Scholar
• Carter E, Bonab A, Goverman J et al. Evaluation of the antioxidant peptide SS31 for treatment of burn-induced insulin resistance. Int. J. Mol. Med. 28(4), 589–594 (2011).
   PubMedGoogle Scholar
• Elijah I, Borsheim Em Maybauer D et al. Role of the PPAR-alpha agonist fenofibrate in severe pediatric burn. Burns 38(4), 481–486 (2012).
   PubMedGoogle Scholar
• Gore D, Wolf S, Sanford A et al. Influence of metformin on glucose intolerance and musclecatabolism following severe burn injury. Ann. Surg. 241(2), 334–342 (2005).
   PubMedGoogle Scholar
• Snell J, Loh N, Mahambrey T, Shokrollahi K. Clinical review: the critical care management of the burn patient. Crit. Care 17(5), 241 (2013).
   Google Scholar
• Jeschke M. Clinical review: glucose control in severely burned patients- current best practice. Crit. Care 17(4), 232 (2013).
   Web of Science ®Google Scholar